Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-02-28 @ 4:57 AM
Study NCT ID:
NCT02720094
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2016-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-21
First Submit QC Date:
None
Study First Post Date:
2016-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-29
Results First Submit QC Date:
None
Results First Post Date:
2023-11-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED